spacer
home > ebr > spring 2002 > 2nd annual bia european ceo & investor conference - 27th-28th november 2001, london
PUBLICATIONS
European Biopharmaceutical Review

2nd Annual BIA European CEO & Investor Conference - 27th-28th November 2001, London

The theme of the BIA's successful 2nd Annual CEO & Investor Conference, held in London towards the end of last year was 'From Promise to Products'. This was a timely choice given the re-focus of investor sentiment which underscored the market conditions for life science investing throughout 2001 and has continued in the first quarter of 2002. The name of the game is developing products to deliver long-term and sustainable value (nothing new there, of course) and this was the underlying proposition behind all of the elements of this two-day conference. Run by the BIA in partnership with Technology Vision Group (TVG), the aim of the CEO & Investor Conference was to provide a platform for both public and private European companies and their investors to present to, and engage with, each other on the product delivery question. This assumed various structured forms including moderated CEO roundtable discussions, which were also co-ordinated to illustrate different case scenarios for acceleration towards products. In addition, there were themed investor panels that focused on innovation in both science and partnering plus the leveraging of intellectual property assets to raise finance. Beyond the parallel CEO and investor panels, the third track featured a series of European company presentations from a range of public and private European companies across multiple technology platforms and therapeutic areas - all with one element in common: the drive towards products.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Helen Abbott, Senior Consultant at Technomark and Editor of EBR
spacer
Dr Helen Abbott
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm accelerates strategy to broaden service offering into commercial manufacturing

MedPharm Ltd, a leading contract provider of topical and transdermal product design and development services, has announced two new appointments to its Board to support plans to grow its commercial manufacturing services.
More info >>

White Papers

Finding the Right End-to-End Safety Solution for Your Needs

Bioclinica

With upcoming changes, including the implementation of the International Conference on Harmonisation (ICH) E2B(R3) Electronic Transmission of Individual Case Safety Report and Identification of Medicinal Products (IDMP) standards, the current state of safety reporting can be confusing. Your existing safety system may not be flexible enough to accommodate these changing regulations, which are still moving targets regarding the details needed for a comprehensive solution with the right level of processes, company-to-company integrations and finalized regional rules.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: itís where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on todayís hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement